Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Surgical Research

• Publication date

  2013-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jss.2013.03.025PMID 23578751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-17A plays a pivotal role in polymicrobial sepsis according to studies using IL-17A knockout mice.

  2012cited by this paper
• Role of IL-17A in Neutrophil Recruitment and Hepatic Injury after Warm Ischemia–Reperfusion Mice

  2011cited by this paper
• The interleukin‐17 pathway is involved in human alcoholic liver disease

  2009cited by this paper
• Dietary olive oil prevents carbon tetrachloride-induced hepatic fibrosis in mice

  2009cited by this paper
• Protective effect of Juzen‐taiho‐to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell‐induced oxidative stress

  2008cited by this paper
• Differential effects of interleukin‐1α, tumor necrosis factor α, and transforming growth factor β1 on cell proliferation and collagen formation by cultured fat‐storing cells

  2008cited by this paper
• The roles of IL‐17A in inflammatory immune responses and host defense against pathogens

  2008cited by this paper
• Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

  2008cited by this paper
• Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

  2007cited by this paper
• Mecanismos de lesión hepatocelular

  2007cited by this paper
• Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways

  2006cited by this paper
• Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways.

  2006cited by this paper
• Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex

  2006cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis.

  2005cited by this paper
• Role of reactive oxygen species in zinc deficiency-induced hepatic stellate cell activation.

  2005cited by this paper
• Interleukin-17 family members and inflammation.

  2004cited by this paper
• Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications

  2004cited by this paper
• Commitment of bone marrow cells to hepatic stellate cells in mouse.

  2004cited by this paper
• Liver fibrosis: from the bench to clinical targets.

  2004cited by this paper
• Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis.

  2002cited by this paper
• Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense

  2001cited by this paper
• Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury*

  2000cited by this paper
• Pathogenesis of liver fibrosis: role of oxidative stress.

  2000cited by this paper
• Cytokine regulation of hepatic stellate cells in liver fibrosis.

  1999cited by this paper
• Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat

  1997cited by this paper
• Oxidative damage and fibrogenesis.

  1997cited by this paper
• Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis.

  1996cited by this paper
• Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis.

  1996cited by this paper
• Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease

  1995cited by this paper
• CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene.

  1993cited by this paper
• The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus.

  1993cited by this paper
• Stimulation of hepatic lipocyte collagen production by Kupffer cell‐derived transforming growth factor β: Implication for a pathogenetic role in alcoholic liver fibrogenesis

  1990cited by this paper
• Cellular Sources of Collagen and Regulation of Collagen Production in Liver

  1990cited by this paper
• Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis.

  1990cited by this paper
• Increased tumor necrosis factor production by monocytes in alcoholic hepatitis

  1989cited by this paper
• Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells.

  1989cited by this paper
• Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis

  1988cited by this paper

• Single-cell RNA-seq reveals immune cell heterogeneity and increased Th17 cells in human fibrotic skin diseases

  2025cites this paper
• LSECtin attenuates hepatic Th17 expansion in a murine model of cirrhosis and signals through the LAG-3 receptor

  2025cites this paper
• Novel RORγt inverse agonists limit IL-17-mediated liver inflammation and fibrosis.

  2025cites this paper
• The interaction between IL-17 and gut microbiota contributes to cholestatic liver disease in children

  2025cites this paper
• Proteomics and cytokine array jointly reveal the role of macrophage proinflammatory shift in liver fibrosis in dairy cows with ketosis

  2025cites this paper
• Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot study

  2025cites this paper
• Immune Checkpoints and the Immunology of Liver Fibrosis

  2025cites this paper
• IL-17 signaling in primary sclerosing cholangitis patient-derived organoids

  2024cites this paper
• Molecular pathological characteristics and mechanisms of the liver in metabolic disease-susceptible transgenic pigs.

  2024cites this paper
• Nutritional and microbiota-based therapeutic intervention for alcohol-associated liver disease: Pathogenesis to therapeutic insights.

  2024cites this paper
• IL-17 Signaling in Primary Sclerosing Cholangitis Patient-Derived Organoids

  2023cites this paper
• Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC‐induced cholestatic injury by promoting a pro‐restorative inflammatory response

  2022cites this paper
• Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis

  2022cites this paper
• The role of Th17 cells in viral infections.

  2021cites this paper
• Circulating non-coding RNAs as potential diagnostic biomarkers in liver diseases

  2021cites this paper
• Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis

  2021cites this paper
• Interaction of non-parenchymal hepatocytes in the process of hepatic fibrosis

  2021cites this paper
• Evaluation Of Possible Antifibrotic Effect Of Cholecalciferol, Calci- Potriol, Aliskiren, Ramipril And Eprosartan On Carbon Tetrachloride Induced Liver Fibrosis In Albino Rats

  2020cites this paper
• Cirrhosis: A Questioned Risk Factor for Hepatocellular Carcinoma.

  2020cites this paper
• Fibrosis: from mechanisms to medicines

  2020cites this paper
• Huagan tongluo Fang improves liver fibrosis via down-regulating miR-184 and up-regulating FOXO1 to inhibit Th17 cell differentiation.

  2020cites this paper
• Hepatocarcinoma–intestine–pancreas/pancreatitis-associated protein (HIP/PAP) confers protection against hepatic fibrosis through downregulation of transforming growth factor β receptor II

  2019cites this paper
• Interleukin-17: Friend or foe in organ fibrosis.

  2019cites this paper
• IL‐17 and TNF‐α co‐operation contributes to the proinflammatory response of hepatic stellate cells

  2019cites this paper
• Pulmonary Complications of Rheumatoid Arthritis

  2019cites this paper
• Systemic effects of IL-17 in inflammatory arthritis

  2019cites this paper
• IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases.

  2018cites this paper
• Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer

  2018cites this paper
• NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL‐17 and TNF in mice

  2018cites this paper
• Green Tea Catechins Effectively Altered Hepatic Fibrogenesis in Rats by Inhibiting ERK and Smad1/2 Phosphorylation.

  2018cites this paper
• The Promising Role of Anti-Fibrotic Agent Halofuginone in Liver Fibrosis/Cirrhosis

  2017cites this paper
• Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis

  2017cites this paper
• Interleukin 17, Produced by γδ T Cells, Contributes to Hepatic Inflammation in a Mouse Model of Biliary Atresia and Is Increased in Livers of Patients.

  2016cites this paper
• The contribution of T cell-derived cytokines and proteases to chronic inflammation in the human intestine

  2016cites this paper
• Interleukin-17A Plays a Pivotal Role in Chemically Induced Hepatocellular Carcinoma in Mice

  2016cites this paper
• Pathogenesis of Kupffer Cells in Cholestatic Liver Injury.

  2016cites this paper
• New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article

  2016cites this paper
• Liver fibrosis in bile duct-ligated rats correlates with increased hepatic IL-17 and TGF-β2 expression.

  2016cites this paper
• Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology?

  2016cites this paper
• IL‐17A produced by both γδ T and Th17 cells promotes renal fibrosis via RANTES‐mediated leukocyte infiltration after renal obstruction

  2015cites this paper
• Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases

  2015influential citation
• Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice

  2015influential citation
• Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.

  2015cites this paper
• Pathogenesis of liver cirrhosis.

  2014cites this paper
• Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases

  2014influential citation
• Macrophages: Biology and Role in the Pathology of Diseases

  2014cites this paper
• Kupffer Cells in Health and Disease

  2014cites this paper
• T Helper 17 Cells in Autoimmune Liver Diseases

  2013cites this paper